Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation
- PMID: 132684
Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation
Abstract
It has been proposed that the etiologies of tardive dyskinesia and Huntington's chorea and of some forms of schizophrenia and the affective disorders involve a cholinergic imbalance with respect to a second neurotransmitter. This relative over- or underactivity of the cholinergic system could result from altered synthesis, storage, release, degradation, or reuptake or from a variety of receptor interactions. Under these hypotheses, clinical symptoms would reflect both the brain region in which the imbalance occurs and the neurotransmitter with which acetylcholine is interacting. Effective treatments could involve the correction of this hypothetical imbalance by changing the relative availability of either one or both of the neurotransmitters. Both precursor loading with choline or dimethylaminoethanol and cholinesterase inhibition may be useful in evaluating the effects of increased cholinergic activity in these disease states; the relative merits of these strategies are discussed.
Similar articles
-
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.Biol Psychiatry. 1978 Feb;13(1):23-49. Biol Psychiatry. 1978. PMID: 146524 Clinical Trial.
-
The use of cholinergic precursors in neuropsychiatric diseases.Am J Clin Nutr. 1982 Oct;36(4):709-20. doi: 10.1093/ajcn/36.4.709. Am J Clin Nutr. 1982. PMID: 6214943 Review.
-
Diagnostic problems in Huntington's chorea and tardive dyskinesia.Compr Psychiatry. 1976 Mar-Apr;17(2):325-33. doi: 10.1016/0010-440x(76)90007-9. Compr Psychiatry. 1976. PMID: 130224 Review. No abstract available.
-
[Neurotransmitters, drugs and neuropsychiatric diseases (author's transl)].Lijec Vjesn. 1979 Oct;101(10):609-16. Lijec Vjesn. 1979. PMID: 44538 Croatian. No abstract available.
-
Proceedings: Cholinergic and adrenergic balance in mania and schizophrenia.Psychopharmacol Bull. 1974 Jul;10(3):49-50. Psychopharmacol Bull. 1974. PMID: 4419332 No abstract available.
Cited by
-
Mood alterations during deanol therapy.Psychopharmacology (Berl). 1979 Apr 11;62(2):187-91. doi: 10.1007/BF00427135. Psychopharmacology (Berl). 1979. PMID: 111283 Clinical Trial.
-
Treating disorders across the lifespan by modulating cholinergic signaling with galantamine.J Neurochem. 2021 Sep;158(6):1359-1380. doi: 10.1111/jnc.15243. Epub 2021 Jan 8. J Neurochem. 2021. PMID: 33219523 Free PMC article. Review.
-
Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice.Pharmacol Biochem Behav. 2012 Mar;101(1):107-14. doi: 10.1016/j.pbb.2011.12.010. Epub 2011 Dec 21. Pharmacol Biochem Behav. 2012. PMID: 22210488 Free PMC article.
-
Central neurotransmitter function and its behavioral correlates in man.Environ Health Perspect. 1978 Oct;26:135-41. doi: 10.1289/ehp.7826135. Environ Health Perspect. 1978. PMID: 31279 Free PMC article. Review.
-
Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.Psychopharmacology (Berl). 1979 Nov;65(3):219-23. doi: 10.1007/BF00492207. Psychopharmacology (Berl). 1979. PMID: 117492 Clinical Trial.